Dry Eye Syndrome Treatment Market

Global Dry Eye Syndrome Treatment Market: Overview

Manufacturers in the global dry eye syndrome treatment market offer solutions for two distinct types of dry eye conditions, namely, aqueous deficient dry eye syndrome, as well as evaporative dry eye syndrome. Some of the leading drugs produced by these players are Xiidra, Eysuvis, Restasis, Tyrvaya, and Cequa, among others. Major types of products manufactured and marketed by players in the global dry eye syndrome treatment market include topical corticosteroids, dissolvable punctal plugs and removable punctal plugs, cyclosporine, oral omega supplements, and artificial tears, among others. Players in the global dry eye syndrome treatment market offer various types of solutions, such as eye solutions, eye drops, gels, ointments, and tablets and capsules. These products are made available to the patients through retail pharmacies, online pharmacies, and hospital pharmacies.

Global Dry Eye Syndrome Treatment Market: Major Trends and Drivers

Leading drivers propelling the growth within the global dry eye syndrome treatment market include rising demand for effective medical treatments, increase in the prevalence of dry eye disorder, and presence of attractive drug and treatment therapeutics pipeline. Furthermore, rising awareness about this condition among the global population is also aiding in the expansion of the market in coming years. While COVID-19 pandemic had a negative impact on the growth of the global dry eye syndrome treatment market, opening of ophthalmic clinics and eye hospitals in post-pandemic era is anticipated to regulate the development trajectory of the industry. Furthermore, an increase in the use of screens as well as rising trend of sedentary lifestyles owing to lockdowns and pandemic, is anticipated to positively influence the growth within the global dry eye syndrome treatment market.

Another key driver for the market’s expansion is the growing elderly population across the world. The elderly population is more prone to this ophthalmic condition as their eyes produce a smaller number of tears which can ultimately lead to dryness and evaporation. However, presence of stringent government regulations pertaining to drugs and treatment solutions, as well as risk of side effects from these long-term drugs may hinder the growth within the global dry eye syndrome treatment market in coming years. On the other hand, rising use of contact lenses and resulting increase in eye dryness is anticipated to bode well for the growth within the global dry eye syndrome treatment market.

Global Dry Eye Syndrome Treatment Market: Key Players and Manufacturers

Some of the most prominent manufacturers and players operating in the global dry eye syndrome treatment market include AbbVie, inc., Santen Pharmaceutical Co., Ltd., Johnson & Johnson Services, Inc., OASIS Medical, Bausch & Lomb, Novartis AG, Sun Pharmaceutical industries Ltd., AFT Pharmaceuticals, Otsuka Pharmaceutical Co., Ltd., and Oyster Point Pharma, Inc., among others. Some of the leading growth strategies employed by these players include product innovations, new product launches, mergers and acquisitions, and research and development. For example, Eysuvis, a drug for short-term treatment of dry eye was made available in retail pharmacies by producer Kala Pharmaceutical, Inc., in January of 2021.

Global Dry Eye Syndrome Treatment Market: Regional Assessment

North America dominated the global dry eye syndrome treatment market in recent past, in terms of revenue share. Some of the key drivers for North America market include enhanced access to healthcare among regional population, increasing rate of adoption of dry eye treatments, and presence of a large target population. Furthermore, increasing entry of new players in the region also bolsters the development trajectory of this market.

Asia Pacific is anticipated to record the highest growth rate in the global dry eye syndrome treatment market in coming years. Some of the leading drivers for the expansion of the Asia Pacific market include increasing efforts made by private and public players to enhance the healthcare infrastructure, increasing prevalence of dry eye disorder, and presence of several dominant players and manufacturers in the region.